“Cancer will probably affect us all at some time, either directly or through family and friends,” said David Clark.
“New Zealanders deserve first-class cancer care and, although most people receive it, our standard of care is variable and we must do more to ensure better outcomes for Maori and Pacific people.”
“We have more work to do, but in the last two years we have made good progress in which we can build for the future.
“In December, Prime Minister Jacinda Ardern and I fulfilled our pre-election promise to improve central leadership and cancer coordination through the establishment of a Cancer Control Agency.
“It’s great to see how our new agency, led by Professor Diana Sarfarti, is working hard on her 100-day work plan to enable her to drive improvements in cancer control across the country.
“Today, we have also launched our updated New Zealand Cancer Action Plan 2019-29, which better reflects the voices of people whose lives are affected by cancer.
“I want to thank the more than 380 people and organizations that shared their knowledge and experiences during the public consultation at the end of last year.
“I am pleased that your extensive comments broadly support the direction of the plan and include ways to strengthen cancer control in our country, which have been added to the plan.
“I am also delighted that the $ 60 million increase in funds for PHARMAC last year is making a difference with five new cancer drugs funded since then.
“I also want to thank PHARMAC’s recent announcement about palbociclib (marketed as Ibrance) for the first and second line treatment of certain types of breast cancer. The decision to make inquiries about their financing is very significant and, ultimately, could benefit more than 2000 New Zealanders in their first year.
“Better access to treatment is also the reason we have invested in 12 new linear accelerators for radiation treatment, including plans to place machines at Hawke’s Bay, Taranaki and Northland for the first time.
“It’s great news that the first of the two new linear accelerators will be operational in Palmerston North in May and the second will be operational later this year.”
“In addition, the National Intestinal Screening Program continues to expand to more DHB and is proving its worth. Recently passed the cancer milestone number 500 detected. That means that the chances of survival and recovery of this disease of 500 New Zealanders have been improved thanks to early detection and treatment.
“Today’s publication of our finalized plan, together with the work of the agency, PHARMAC and the health sector in general, is part of a continuous and determined effort by the team to improve cancer outcomes for New Zealanders who will continue to function. in the next few years, “David Clark said.
/ Public launch. See in full here.